Zimmer Biomet has completed the previously announced acquisition of Paragon 28 for an enterprise value of approximately $1.2bn. Announced in January, the acquisition is set to widen and bolster Zimmer ...

Shares of NYSE FNA opened at $13.08 on Monday. The stock has a market capitalization of $1.10 billion, a price-to-earnings ratio of -17.68 and a beta of 1.47. Paragon 28 has a 52 week low of $4.65 ...

Explore PARAGON 28 INC COM stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FNA. Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details Zimmer ...

Zimmer Biomet reported Street-beating Q1 results and upped its revenue guidance, though it cut its EPS projections amid ...

"We look forward to building on the strong foundation set by Albert DeCosta and the Paragon 28 team and are excited to officially welcome them to the Zimmer Biomet family," said Ivan Tornos ...

The orthopedics company lowered its earnings forecast, accounting for the tariffs and closing the acquisition of Paragon 28.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WARSAW, Ind., April 21, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. ("Zimmer Biomet"; NYSE and SIX: ZBH), a global medical technology leader, today announced it has completed the ...

Warsaw-based Zimmer Biomet Holdings, Inc. has completed the acquisition of Paragon 28 Inc., a medical device company focused exclusively on the fast-growing foot and ankle orthopedic space.